Christine Lindenboom | Senior Vice President of Investor Relations |
John Maraganore | Chief Executive Officer |
Barry Greene | President |
Akshay Vaishnaw | President of R&D |
Jeffrey Poulton | Chief Financial Officer |
Yvonne Greenstreet | Chief Operating Officer |
Andy Orth | Head of the U.S. Business |
Paul Matteis | Stifel Nicolaus |
Alethia Young | Cantor Fitzgerald |
Anupam Rama | J.P. Morgan |
Tazeen Ahmad | Bank of America Securities |
Maury Raycroft | Jefferies |
Ritu Baral | Cowen |
David Lebowitz | Morgan Stanley |
Vincent Chen | Bernstein |
Salveen Richter | Goldman Sachs |
Gena Wang | Barclays |
Alan Carr | Needham |
Mani Foroohar | SVB Leerink |
Navin Jacob | UBS |
Ladies and gentlemen, thank you for standing-by. Welcome to the Alnylam Pharmaceuticals Conference Call Second Quarter 2020. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request. I would now like to turn the call over to the company.